SCHEMBL5504743

SCHEMBL5504743

CCN(CCC(N)=O)c1ccc(F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.47
▸ ALDH1A1 P00352 4/20 0.47
▸ GAA P10253 3/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ THRB P10828 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ CNR2 P34972 3/20 0.41
▸ TDP1 Q9NUW8 2/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ GFER P55789 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ PSMD14 O00487 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ AOC3 Q16853 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3868884 0.83 MEN1 (0.47) MAPTALDH1A1GAAHTTCNR2
SCHEMBL6555114 0.80 ALDH1A1 (0.39) MAPTALDH1A1GAAKDM4EMAPK1
SCHEMBL9197023 0.78 S100B (0.66) MAPTALDH1A1GAAMAPK1HTT
SCHEMBL15741279 0.77 ALDH1A1 (0.54) MAPTALDH1A1GAAKDM4EMAPK1
SCHEMBL6984098 0.75 ALDH1A1 (0.66) MAPTALDH1A1GAAKDM4EMAPK1
SCHEMBL12227010 0.75 PARP1 (0.44) ALDH1A1GAAKDM4ETHRBGFER
SCHEMBL6443035 0.74 ALDH1A1 (0.51) MAPTALDH1A1GAAKDM4EMAPK1
SCHEMBL9463877 0.74 MAPT (0.51) MAPTALDH1A1GAAKDM4EMAPK1
SCHEMBL22504113 0.72 AOC3 (0.58) MAPTALDH1A1GAAKDM4EMAPK1
SCHEMBL11222351 0.71 ALDH1A1 (0.60) MAPTALDH1A1GAAKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799645-A2 PROCESSES AND INTERMEDIATES FOR PREPARING CYSTEINE PROTEASE INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2007-06-27 — — EP disclosed
WO-2006034004-A2 PROCESSES AND INTERMEDIATES FOR PREPARING CYSTEINE PROTEASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2006-03-30 — — WO disclosed
Send feedback